The liver is the most important organ involved in lipid metabolism. People with high cholesterol levels present overstressed liver and an increased oxidative stress.

Moreover, they may have a complicated clinical status: hypertension, kidney disfunctions and hyperglycemia may be associated to hypercholesterolemia. 

The majority of natural and synthetic ingredients, already present in the market, only decrease cholesterol levels.

Omeolipid is an association of Artichoke (Cynara scolymus L.), Caihua (Cyclanthera pedata (L.) Schrad.) and Fenu greek (Trigonella foenum-graecum L.) that can be used in food supplements for its anti-cholesterolemic and cholagogue properties.

Omeolipid has strong hepatoprotective, antioxidant and depurative effects, supporting liver functionality.

Moreover, Omeolipid promotes bile production and flow, which is essential for cholesterol clearance; in addition, it decreases gut absorption of cholesterol, therefore its uptake.

Omeolipid  acts as hypoglycemic and hypothensive agent and alleviates problems related to kidney disfunctions.

Omeolipid combines the traditions of three different countries:

Artichoke is a Mediterranean plant; its cultivation in Europe dates back to ancient Greece and Rome. Its active substances (caffeoylquinic acids, flavonoids, sesquiterpene lactones) are concentrated in the leaf, acting as digestive, colagougue, hepatoprotective and depurative.

Caihua is a traditional plant from South America; the fruit contains flavonoids and in Peru its use is documented since 3700 b.C. as hypothensive, antidiabetic, anti-inflammatory and hypocholesterolemic.

Fenu greek is a milestone of the Ayurvedic medicine, alleviating kapha and vata. The seeds contain saponines, coumarines, flavonoids and alkaloids. They have hypocholesterolemic, diuretic, diaphoretic, carminative, hypoglycemic, demulcent properties and they are traditionally used to treat obesity and diabetes.

Download the in vitro experiments carried out on Omeolipid.